CNS/Brain Cancer
From the Journals
Persistent hair loss after radiation improved with minoxidil
Clinical Insights
Artificial intelligence matches cancer genotypes to patient phenotypes
From the Journals
Hepatitis screening now for all patients with cancer on therapy
All patients with cancer who are candidates for systemic therapy should be screened for hepatitis B, says the American Society of Clinical...
Feature
ASCO says ‘no’ to home infusions of cancer treatment, with exceptions
The American Society of Clinical Oncology has warned against intravenous infusion of chemotherapy and monoclonal antibodies in cancer patients’...
From the Journals
OK to treat many cancer patients despite pandemic, says ESMO
ESMO recommends against stopping or delaying cancer treatment that can impact survival.
From the Journals
Intraventricular methotrexate may improve survival for medulloblastoma subtypes
Patients with desmoplastic medulloblastoma or medulloblastoma with extensive nodularity had high survival rates after receiving systemic...
From the Journals
Early data support further study of ivosidenib in mIDH1 glioma
The median progression-free survival was longer in patients with nonenhancing, versus enhancing, IDH1-mutated glioma.
Conference Coverage
Analysis of early onset cancers suggests need for genetic testing
The prevalence of germline mutations was significantly higher in patients with early onset cancers than in those with young adult cancers.
News from the FDA/CDC
FDA approves new indications for pembrolizumab
Conference Coverage
Tumor markers are ‘valuable’ for relapse detection in rare CNS tumors
Among evaluable patients, 92% of relapses were detectable by tumor markers.
Feature
Can an app guide cancer treatment decisions during the pandemic?